Trials / Sponsors / TLA, Targeted Immunotherapies AB
TLA, Targeted Immunotherapies AB
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Dose-Evaluation Study of the Efficacy and Safety of TLA Gut™ Leukapheresis Treatment in Patients With Ulcerati Ulcerative Colitis (UC) | N/A | 2022-12-01 |